Short Interest in STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Declines By 17.1%

STRATA Skin Sciences, Inc. (NASDAQ:SSKN) was the target of a large decrease in short interest in the month of November. As of November 30th, there was short interest totalling 5,800 shares, a decrease of 17.1% from the November 15th total of 7,000 shares. Based on an average trading volume of 11,200 shares, the short-interest ratio is presently 0.5 days. Approximately 0.2% of the shares of the company are sold short.

Institutional Investors Weigh In On STRATA Skin Sciences

An institutional investor recently bought a new position in STRATA Skin Sciences stock. Azzad Asset Management Inc. ADV purchased a new stake in shares of STRATA Skin Sciences, Inc. (NASDAQ:SSKN) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 12,000 shares of the medical device company’s stock, valued at approximately $33,000. Azzad Asset Management Inc. ADV owned 0.34% of STRATA Skin Sciences at the end of the most recent reporting period. Institutional investors and hedge funds own 32.43% of the company’s stock.

STRATA Skin Sciences Stock Performance

Shares of NASDAQ SSKN opened at $3.00 on Friday. The firm’s 50-day moving average price is $3.02 and its 200-day moving average price is $3.10. STRATA Skin Sciences has a 52-week low of $2.51 and a 52-week high of $6.90. The company has a market cap of $12.49 million, a PE ratio of -1.13 and a beta of 1.32. The company has a quick ratio of 0.94, a current ratio of 1.13 and a debt-to-equity ratio of 1.62.

STRATA Skin Sciences Company Profile

STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.